Egypt signs strategic agreements to advance vaccine and serum localisation
Egypt’s Deputy Prime Minister for Human Development and Minister of Health and Population, Khaled Abdel Ghaffar, attended the signing ceremony of three strategic cooperation agreements focused on technology transfer and the localisation of vaccine and serum production, TV BRICS reports.
According to the source, the agreements establish cooperation between national and international institutions specialising in vaccines, pharmaceuticals, regenerative medicine and biomedical research. The partnerships are aimed at facilitating the transfer of advanced technologies and supporting the localisation of biopharmaceutical production in Egypt.
The partnerships are intended to facilitate the transfer of advanced technologies and support the localisation of biopharmaceutical industries in Egypt. The initiative is expected to strengthen the country’s pharmaceutical and health security while enhancing domestic research, development, and manufacturing capabilities.
Abdel Ghaffar noted that the agreements represent an important step in Egypt’s strategy to localise advanced biopharmaceutical industries and expand international partnerships for the transfer of expertise and modern technologies. The move is aimed at achieving greater self-sufficiency in vaccine and serum production and strengthening the country’s ability to respond to public health challenges.
The signing ceremony was attended by Ali El-Ghamrawy, Chairman of the Egyptian Drug Authority, and Hisham Stait, Chairman of the Egyptian Authority for Unified Procurement, Medical Supply and Technology Management, alongside senior health officials and representatives of relevant institutions.
Earlier, Qazinform reported scientists test an AI-designed universal coronavirus vaccine.
